Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, plexiform neurofibromaActive, not recruitingPhase 1 / Phase 22024-11-12NCT04954001

1 results · Page 1 of 1

Swipe the table sideways for more columns.

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital Los AngelesLos AngelesUnited States226
Henry Ford Health SystemDetroitUnited States147
Hospital Universitario 12 De OctubreMadridSpain98
Hospital Universitario La PazMadridSpain75
Hospital Universitario Vall d'HebronBarcelonaSpain27
John Hopkins All Children HospitalSt. PetersburgUnited States1
Medical University of South Carolina - Hollings Cancer Center - PPDSCharlestonUnited States1
Principal Investigator HansGainesvilleUnited States1